Clinical trial
Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint…
NCT00422006 · Nantes University Hospital, Other · Completed
Key facts
| NCT number | NCT00422006 |
|---|---|
| Title | Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance |
| Official title | Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Behavioral, Other, Procedure |
| Interventions | biopsy of muscle, of liver, and of adipose tissue, clamp euglycemic - hyperglycemic, diet, biopsies for biological and genetic analyses |
| Enrollment | 111 |
| Start date | Feb 1, 2008 |
| Primary completion | Nov 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Jan 15, 2007 |
| Last update posted | Apr 3, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: